Wegovy (semaglutide) is a GLP-1 receptor agonist specifically approved for chronic weight management in individuals with obesity or overweight individuals with weight-related conditions
Methylene Blue Toxicity Its rare for someone to have methylene blue toxicity, or an overdose of methylene in their system
Transitioning Off GLP-1 Medications For patients considering discontinuation of GLP-1 medications, it is essential to adopt sustainable lifestyle changes to prevent weight regain
GLP-1 powerfully slows how quickly your stomach empties food into your intestines, contributing to prolonged fullness
The currently available GLP-1 RAs, which act by mimicking the actions of endogenous GLP-1, are exenatide, liraglutide, albiglutide, lixisenatide, dulaglutide, and semaglutide